RadiAid
Strategic Impact Assessment
Our innovation aims to save lives by catching bone cancer early. But like all powerful technologies, it has both positive and negative consequences.
-
Earlier Diagnosis
The current 4.5-month delay often means the difference between limb-saving surgery and amputation, or curable disease and fatal spread. Our system could catch cases within days instead of months. -
Preserved Limbs
A 14-year-old who gets limb-saving surgery instead of amputation faces a completely different future. Where prosthetic care is limited, keeping a limb might determine whether a child can go to school or support themselves. -
Better Resource Allocation
By accurately identifying which patients need specialist review, our system lets experts focus on complex cases that require human judgment. -
Cost Savings
Early diagnosis saves money. Treating localized osteosarcoma needs chemotherapy and surgery (expensive but curative). Treating spread disease needs more intensive treatment and long hospital stays, yet offers worse survival.
Positive Consequences
-
False Positives
Benign conditions incorrectly flagged as potential cancer create real harm. Families may travel far and spend money to see a specialist, only to learn it's benign. This creates anxiety and erodes trust. -
Data Privacy
Though our offline design keeps images local, federated learning uploads model parameters. Strong encryption and transparent policies must be built in. -
Access Disparities
Some clinics will adopt quickly while others lag, creating temporary inequalities. Wide rollout becomes morally necessary once the tool is proven effective. -
System-Level Challenges
If our tool increases referrals but specialty centers can't treat more patients, outcomes don't improve. Real impact requires fitting AI into complete cancer care systems.
Negative Consequences
Conclusion: Our Responsibility
Success isn't measured by accuracy in controlled studies, but by real-world impact: lives saved, limbs kept, suffering prevented. The nine-year-old girl in Uganda died because the healthcare system lacked tools to catch her cancer early. Our innovation aims to provide those tools thoughtfully and responsibly. If we succeed, future stories will have different endings: children diagnosed early, treated successfully, and given the chance to grow up and live full lives.